Navigation Links
For Atrial Fibrillation, Surveyed Experts Indicate That Multaq, Celivarone and ATI-2042 Have Advantages Over Propafenone in the Maintenance of Normal Sinus Rhythm
Date:4/21/2009

Multaq Will Earn Decision Resources' Clinical Gold Standard Status for Atrial Fibrillation in 2012, According to a New Report from Decision Resources

WALTHAM, Mass., April 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed cardiologists identify a therapy's effect on mortality as the attribute that most influences their prescribing decisions in maintenance of normal sinus rhythm in atrial fibrillation. Clinical data and the opinions of interviewed thought leaders indicate that Sanofi-Aventis's Multaq and celivarone, and Aryx Therapeutics' ATI-2042 have advantages in this attribute over propafenone (GlaxoSmithKline/Abbott's Rythmol/Rythmonorm, generics), the sales-leading antiarrhythmic agent in the market.

The new report entitled Atrial Fibrillation: Opportunity Awaits Antiarrhythmics with Improved Safety and Anticoagulants Without Routine Monitoring also finds that an anticoagulant for the prevention of stroke in atrial fibrillation that does not require routine monitoring would earn a 53 percent patient share in the United States and a 55 percent patient share in Europe, according to surveyed U.S. and European cardiologists.

In 2008, Decision Resources' proprietary clinical gold standard for the maintenance of normal sinus rhythm in atrial fibrillation was amiodarone (Sanofi-Aventis/Wyeth's Cordarone, generics). Based on available data and expert opinion, Multaq will earn gold standard status for maintenance of normal sinus rhythm in atrial fibrillation in 2012, following its approval for the indication in 2009. Additionally, following its approval in 2014, ATI-2042 will earn gold-standard status for the indication in 2017.

"Multaq and ATI-2042 have competitive advantages over other emerging therapies because they have been designed to have efficacy similar to that of amiodarone
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Larger Men at Greater Risk for Atrial Fibrillation
2. Big men more susceptible to atrial fibrillation
3. For Prevention of Stroke, Surveyed Cardiologists and PCPs Expect to Prescribe Xarelto to Approximately One-Third of Newly-Diagnosed Atrial Fibrillation Patients
4. Boehringer Ingelheim Plans to Launch U.S. Registry to Assess the State of Anticoagulation Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
5. Final Patient Completes Treatment In Boehringer Ingelheims RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
6. Austin, Texas, Physicians Second in Nation to Perform New Procedure for Difficult-to-Treat Atrial Fibrillation Cases
7. Increasing Use of Ablation to Treat Atrial Fibrillation
8. Defect in Gene Tied to Atrial Fibrillation
9. Novel Anticoagulants Will Garner More Than Three-Quarters of the Atrial Fibrillation Drug Market in 2017
10. Innovative Atrial Fibrillation (AF) Catheter Ablation System From Ablation Frontiers is Subject of Two Abstracts at Heart Rhythm Congress UK
11. Novel imaging approach may assist in predicting success of treatment for atrial fibrillation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...economic burdens, study predicts , , FRI...ple with diabetes in the United States is expected...dicts. , That would bring the total by 2034 to ...m 23.7 million today. , , At the same time, the ... the study also warns, rising from an estimated $1...
(Date:11/27/2009)...rers who use medical load cells at the heart of th...nging in technology partner Flintec early in the d...dical manufacturers are calling in Flintec load ce... ensuring that progress will not be constrained by... technology. , (PRWEB) No...
(Date:11/26/2009)...s living with diabetes will nearly double, increas...034. Over the same period, spending on diabetes wi... billion, even with no increase in the prevalence ... Chicago report in the December issue of Diabetes...red by Medicare will rise from 8.2 million to 14.6...
(Date:11/26/2009)... the North Pole, Textsanta.net lets parents sign u... North Pole, AK (PRWEB) -- In ...the North Pole Santa Claus has added SMS text mess...ormed of his Christmas progress at the North Pole....ve identified a large and growing percentage of Am...
(Date:11/26/2009)....A. is offering free nationwide confidential consu... pills who have suffered a Deep Vein Thrombosis (D...ther related cardiac issues or had their Gallbladd...6405 or go to the firm’s website at http://...uation form. , (PRWEB) No...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...1998 to 301 in 2006, the maternal mortality ratio ...dbirth //has been falling in India, albeit gradual...od Day Wednesday, it hopes to reduce the MMR rate,... that works to ensure safe motherhood, credits the...
...with Parkinson's disease are less likely to smoke ...y members who do not have the disease//, according...caffeine and taking non-steroidal anti-inflammator...ng to background information in the article. Howev...
...ished in the April 10, 2007, issue of Neurology, h... disease in patients// suffering ‘Restless Legs Sy...tients. For the study, conducted at the Univ...eg movements and blood pressure changes. RLS is a ...
...eport has come out with news that would gladden th...nies, as well as strike fear// in the minds of th...r Peter Singer of the McLaughlin-Rotman Center for...ers about 21 Indian biotechnology companies. ...
... data released by Banfield, The Pet Hospital, one ...he US, nearly 39,000 cats and dogs// were sickened...mination with an industrial chemical. The d...pet food. Described as one of the largest in U.S. ...
...cident can change a person's entire life from one ...njury often takes less time// to heal than the psy...ts differently to shock," says Erneli Martens, a p...reaming is seldom the case, she says. "Some people...
Other Medicine News:Health News:Ray of Hope for Women on Motherhood Day 2Health News:Smoking and Caffeine Inversely Associated With Parkinson's Disease 2Health News:Restless Legs Syndrome Poses Risk of Cardiovascular Disease 2Health News:India’s Biotech Companies- Jumbos Waiting to Gro 2Health News:Melamine Contamination Killed Thousands of Pets, Says a New Report 2Health News:Accident Victims Often Need Psychological Help 2
(Date:11/25/2009)...swire-USNewswire/ -- Remedium Technologies Inc., a... stops severe bleeding, won first prize and $10,00...the Global Security Challenge 2009, company offici...100 entries from around the world, Remedium,s team...t conference held at the London School of Business...
(Date:11/25/2009)...wswire/ -- Regado Biosciences, a privately held co...tamers with active control agents, announced that ...nting at the Piper Jaffray 21st Annual Health Care...rk City. Dr. Mazzo,s presentation will be given a...lude an overview of the Company,s pipeline with em...
(Date:11/25/2009).../ -- Reportlinker.com announces that a new market ..., United States Dental Devices Market Analysis a...er.com/p0158733/United-States-Dental-Devices-Marke...d States Dental Devices Market Analysis and Foreca...n essential source for in-depth information and da...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Making more efficient fuel cells 9811 1Largest ever Alzheimers genome study unveils dementia mysteries 9809 1Largest ever Alzheimers genome study unveils dementia mysteries 9809 2Largest ever Alzheimers genome study unveils dementia mysteries 9809 3Veterans to TEE Off in Iowa City at National Tournament 56329 1Veterans to TEE Off in Iowa City at National Tournament 56329 2
...KVILLE, Md., May 5th Scientists from University o...land and OriGene,Technologies joined effort in cre...nearly all predicted human protein kinases, includ...ent counterparts. Equipped with,this collection, t...gulators in Hedgehog signaling pathway and in acti...
...trogen Continues to be Gold Standard for Managemen...ical specialists from,around the country will gath...tetrics and gynecology, and menopause and estrogen... "Estrogen therapy continues to be the gold stand...mmon physical sign of menopause," said Dr. Ricki,P...
Other Medicine Technology:Latest Cell Publication Describes the Novel Kinase Regulators Using OriGene's Functional Kinome Collection 2Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause 2Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause 3
Albumin (BCP)
Albumin Reagent
AST (SGOT) Reagent (Colorimetric, Endpoint Procedure)
Midas II Stainer
Medicine Products: